Non-coding (nc) RNAs and breast cancer treatment related sequelae: Current evidence and perspectives

Keyphrases

• Non-coding RNA (ncRNA) 100%
• Breast Cancer Treatment 100%
• Treatment-related Sequelae 100%
• Oxidative Stress 33%
• Non-coding 33%
• Quality of Life 33%
• Inflammation 33%
• Breast Cancer 33%
• Apoptosis 33%
• Molecular Mechanism 33%
• Malignancy 33%
• Survival Rate 33%
• Survivors 33%
• MicroRNA 33%
• Long Non-coding RNA (LncRNA) 33%
• Improved Survival 33%
• Molecular Processes 33%
• Neuropathy 33%
• Chemotherapy 33%
• Diagnostic Tool 33%
• Treatment Efficacy 33%
• Fibrosis 33%
• Circular RNA 33%
• Radiotherapy 33%
• Therapeutic Tool 33%
• RNA-RNA 33%
• Treatment-related 33%
• Cardiotoxicity 33%
• Long-term Adverse Effects 33%
• Extracellular Matrix Remodeling 33%
• Survivorship 33%
• RNA Biology 33%
• Personalized Cancer Therapy 33%
• Cellular Process 33%
• Prognostic Tool 33%
• Stress Matrix 33%
• Endocrine Therapy 33%
• Vital Process 33%

Medicine and Dentistry

• Untranslated RNA 100%
• Breast Cancer 100%
• Cancer Therapy 100%
• Sequela 100%
• Side Effect 66%
• Malignant Neoplasm 33%
• Programmed Cell Death 33%
• microRNA 33%
• Extracellular Matrix 33%
• Long Untranslated RNA 33%
• Quality of Life 33%
• Oxidative Stress 33%
• Survival Rate 33%
• Inflammation 33%
• Cancer 33%
• Hormone Therapy 33%
• Fibrosis 33%
• Neuropathy 33%
• Cardiotoxicity 33%
• Radiation Therapy 33%
• Chemotherapy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Untranslated RNA 100%
• Breast Cancer 100%
• Side Effect 66%
• Endocrine Therapy 33%
• Cardiotoxicity 33%
• Cellular Processes 33%
• Malignant Neoplasm 33%
• Long Untranslated RNA 33%
• microRNA 33%
• Chemotherapy Regimens 33%
• Inflammation 33%
• Fibrosis 33%
• Survival Rate 33%
• Neuropathy 33%